A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease

Abstract

Our data suggest that the RETN -420C-to-G variant is associated with increased CRP levels in patients with stable CAD, suggesting that the RETN -420C>G polymorphism may be potentially involved in the inflammatory component of atherogenesis through an enhanced production of CRP.